-+ 0.00%
-+ 0.00%
-+ 0.00%

Alvotech H1 FY26 adjusted EBITDA drops 12.7% to USD 46.9 million; revenue falls 30.8% to USD 211.9 million

PUBT·08/19/2026 20:31:05
Listen to the news
Alvotech H1 FY26 adjusted EBITDA drops 12.7% to USD 46.9 million; revenue falls 30.8% to USD 211.9 million
  • Alvotech posted adjusted revenue of USD 211.9 million, down 30.8% from a year earlier.
  • Adjusted EBITDA fell 12.7% to USD 46.9 million; gross margin held at 54%, down 1 percentage point.
  • Product and service revenue slid 48.3% to USD 105.9 million; license and other revenue rose 4.4% to USD 105.7 million.
  • Cash balance ended at USD 142.8 million, down from Dec. 31, 2025; raised about USD 165 million in equity financing.
  • Resubmitted U.S. BLAs for AVT05 and AVT06; FDA decisions anticipated in Q4 2026, with full-year revenue seen at USD 650-700 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alvotech SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608191630PRIMZONEFULLFEED1001258420) on August 19, 2026, and is solely responsible for the information contained therein.